The acquisition, partially funded with seller financing will be immediately accretive and is expected to add $10 million in annual revenues to Graymark Healthcare.
Stanton Nelson, CEO of Graymark Healthcare, said: “Our subsidiary, ApothecaryRX, is on target with its plan for growth through acquisitions. We feel that calendar year 2008 should show continued growth in both areas of our healthcare operations.”